"10.1371_journal.pone.0135521","plos one","2015-08-13T00:00:00Z","Toshiyuki Ishii; Shunichiro Iwasawa; Ryota Kurimoto; Akemi Maeda; Yuichi Takiguchi; Makoto Kaneda","Department of Physiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113–8602, Japan; Department of Medical Oncology, Graduate School of Medicine, Chiba University1-8-1, Inohana Chuo-ku, Chiba 260–8670, Japan; Tokyo Medical Care and Welfare Vocational School, 1-11-11 Hatchobori, Chuo-ku, Tokyo, 104–0032, Japan","Conceived and designed the experiments: YT TI MK. Performed the experiments: TI AM MK. Analyzed the data: TI SI RK AM YT MK. Contributed reagents/materials/analysis tools: YT TI MK. Wrote the paper: TI SI RK AM YT MK. Obtained permission for use of alectinib: YT.","Yuchi Takiguchi received research fundings from Pfizer Japan, AstraZeneca Japan and Chugai Pharmaceutical Co., and honoraria for speech from Pfizer Japan, AstraZeneca Japan and Chugai Pharmaceutical Co. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","08","Toshiyuki Ishii","TI",6,TRUE,3,3,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
